NafarelinHormone TherapySafety Rating 8/10
Primary research areaEndometriosis
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range200-400 mcg intranasal twice daily
AdministrationNasal spray
Safety8/10 · FDA-approved (Synarel)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Nafarelin
Mechanism of action
GnRH agonist nasal delivery for continuous gonadotropin suppression
Safety profile
Hot flashes, decreased libido, bone density changes · Approved for endometriosis/precocious puberty; nasal delivery; standard GnRH profile
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Nafarelin below your target.
Related pages